Cargando…
Corrigendum: Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis
Autores principales: | Li, Li-Man, Chen, Chang, Ran, Ruo-Xi, Huang, Jing-Tao, Sun, Hui-Lung, Zeng, Chang, Zhang, Zhou, Zhang, Wei, Liu, Song-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453450/ https://www.ncbi.nlm.nih.gov/pubmed/34557419 http://dx.doi.org/10.3389/fonc.2021.746958 |
Ejemplares similares
-
Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis
por: Li, Li-Man, et al.
Publicado: (2021) -
TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
por: Lai, Hui‐Huang, et al.
Publicado: (2019) -
TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer
por: Wang, Ming-Yang, et al.
Publicado: (2019) -
SUMOylation of TARBP2 regulates miRNA/siRNA efficiency
por: Chen, Cheng, et al.
Publicado: (2015) -
Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma
por: Caramuta, Stefano, et al.
Publicado: (2013)